ARUP Consult Editorial Board
The six-member Editorial Board made up of University of Utah Department of Pathology faculty helps lead innovative and ongoing improvements to ARUP Consult. Members work with the ARUP Consult editorial team to establish development goals and set priorities, and to periodically review and update the Consult Editorial Policy.
ARUP Consult Editorial Board members include (left to right): Fred Strathmann, Eszter Lazar-Molnar, Brian Jackson, Bo Hong, Alan Brown, and Reha Toydemir.
Alan F. Brown, MD
Molecular Genetics Pathology Fellow at the University of Utah School of Medicine/ARUP Laboratories
Dr. Brown attended medical school and completed his residency in AP/CP pathology at the University of Texas Health Science Center at San Antonio in 2015. His primary research interests focus on hematopathology, including primary cutaneous lymphomas, myeloproliferative neoplasms, and clonality studies.
Bo Hong, MD
Assistant Professor of Pathology at the University of Utah School of Medicine
Medical Director of Cytogenetics and Microarray at ARUP Laboratories
Dr. Hong is an assistant professor of pathology at University of Utah School of Medicine. She received her MD from Beijing Medical University and completed a residency in internal medicine and hematology at People’s Hospital, Beijing Medical University. Dr. Hong completed a clinical cytogenetics fellowship at the University of Utah and is board certified by the American Board of Medical Genetics and Genomics. She is a fellow of the American College of Medical Genetics and Genomics.
Her academic interests include the clinical significance of cytogenetic findings in hematologic malignancies, particularly in pediatric leukemia.
Brian R. Jackson, MD, MS
Associate Professor of Pathology at the University of Utah School of Medicine
Vice President and Chief Medical Informatics Officer at ARUP Laboratories
Medical Director of Referral Testing at ARUP
Dr. Jackson directs the Informatics Department at ARUP, including ARUP Consult®, decision support, test utilization management, and software product management. He received his BA in mathematics, his MS in medical informatics, and his MD from the University of Utah, and completed a clinical pathology residency at Dartmouth-Hitchcock Medical Center. Before joining ARUP, Dr. Jackson was a staff clinical pathologist and informaticist at Dartmouth-Hitchcock Medical Center, a product manager for a Belgium-based medical software firm, and a National Library of Medicine informatics fellow at the University of Utah.
Dr. Jackson’s research interests include economic analysis of diagnostic testing and physician utilization of laboratory tests. He is certified in clinical pathology by the American Board of Pathology.
Allison Kierstead, MD
ARUP Physician Content Developer
Physician, ARUP Family Health Clinic
Adjunct Professor of Internal Medicine at the University of Utah School of Medicine
As physician content developer for Informatics Decision Support, Dr. Kierstead helps direct, write, and edit ARUP Consult®, Additional Technical Information (ATI) documents, ordering recommendations on the Laboratory Test Directory (LTD), and other ARUP tools that help clinicians make better decisions about laboratory testing and interpretation.
Certified by the American Board of Internal Medicine, Dr. Kierstead received her medical degree from the University of Utah School of Medicine, and completed her medical residency with University of Utah Hospitals and Clinics (UUHC). She practiced internal medicine for three years as part of the University of Utah Healthcare Community Physician Group, and also spent five years in General Internal Medicine at St. Mark’s Hospital. She continues her clinical practice as a physician at the ARUP Family Health Clinic.
Before becoming a physician, Dr. Kierstead worked in the pharmaceutical research field for 10 years after graduating with a bachelor’s of arts degree in biology from Middlebury College. An endurance and adventure racer, her interests include chronic disease management and preventive health and wellness.
Eszter Lazar-Molnar, PhD, D(ABMLI)
Assistant Professor of Pathology at the University of Utah School of Medicine
Assistant Director of the Histocompatibility and Immunogenetics Laboratory at University of Utah Healthcare
Medical Director of Immunology at ARUP Laboratories
Dr. Lazar-Molnar received her PhD in biological sciences at the Semmelweis University in Budapest, Hungary. She completed a postdoctoral fellowship in the laboratory of Dr. Stanley G. Nathenson at the Albert Einstein College of Medicine in New York, where she studied immune regulation through co-stimulatory molecules and finding new ways for designing immunotherapy. She received a Cancer Research Institute postdoctoral fellowship and the Belfer Outstanding Postdoctoral Research Award in 2009. She also completed a clinical immunology fellowship at the University of Utah. Dr. Lazar-Molnar is board certified by the American Board of Medical Laboratory Immunology.
Dr. Lazar-Molnar has been the recipient of several honors and awards, most recently the Clinical Immunology Society Travel Award to the 2015 Primary Immunodeficiency Diseases Summer School.
Her research interests include cellular immunology, immunotherapy, and transplantation immunology.
Frederick Strathmann, PhD, MS
Assistant Professor of Pathology and Associate Member of the Interdepartmental Program in Neuroscience at the University of Utah School of Medicine
Medical Director of Toxicology at ARUP Laboratories
Director of High-Complexity Platforms – Mass Spectrometry at ARUP
Interim Scientific Director of Biocomputing at ARUP
Assistant Director of the ARUP Institute for Clinical & Experimental Pathology® at ARUP
Dr. Strathmann received his MS and PhD in pathology and laboratory medicine at the University of Rochester in New York, completed a clinical chemistry fellowship at the University of Washington in Seattle, and is ABCC board certified in clinical chemistry and toxicological chemistry.
Dr. Strathmann was the recipient of the 2009 AACC Upstate New York Max E. Chilcote Young Investigator Award and a travel award recipient to the 2010 MSACL conference. He was awarded the Strandjord-Clayson Award for Meritorious Research from the Department of Laboratory Medicine at the University of Washington in 2010, the Paul E. Strandjord Young Investigator Award from the Academy of Clinical Physicians and Scientists in 2010 and 2011 and the Young Clinical Scientist Award (Technology Development) from the Association of Clinical Scientists in 2013.
Dr. Strathmann’s basic research interest is in exploring how astrocytes influence their environment during development, disease, and repair of the central nervous system. His clinical focus is in trace and toxic element analysis and clinical mass spectrometry.
Reha M. Toydemir, MD, PhD, FACMG
Assistant Professor of Pathology and Adjunct Assistant Professor of Pediatrics at the University of Utah School of Medicine
Director of the Clinical Cytogenetics Fellowship at the U of U School of Medicine
Medical Director of Cytogenetics and Genomic Microarray at ARUP Laboratories
Dr. Toydemir was a fellow in cytogenetics at ARUP Laboratories and a previous postdoctoral associate in the Human Genetics Department at the University of Utah. He completed his PhD in genetics at the University of Utah and his MD at the University of Ankara, School of Medicine, in Turkey.
Dr. Toydemir was the recipient of the 2007 James W. Prahl Award for Outstanding Contributions by a Graduate Student in the biological or biomedical science at the University of Utah, and is a member of the American Society of Human Genetics and Turkish Society of Medical Genetics.
Dr. Toydemir’s research interests focus on understanding the genetic basis of congenital musculoskeletal abnormalities, especially those affecting the distal joints. He also conducts research on nonsyndromic developmental dysplasia of the hip, utilizing classical mapping methods as well as next generation sequencing technology. Other interests include implementation of advanced genetic technologies in detection and characterization of chromosome aberrations in hematological malignancies.